Sickle cell disease--pathophysiology and treatment

Curr Probl Pediatr Adolesc Health Care. 2006 Nov-Dec;36(10):346-76. doi: 10.1016/j.cppeds.2006.07.002.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Age Factors
  • Analgesics, Non-Narcotic / administration & dosage
  • Analgesics, Non-Narcotic / therapeutic use
  • Analgesics, Opioid / administration & dosage
  • Analgesics, Opioid / therapeutic use
  • Anemia, Sickle Cell* / complications
  • Anemia, Sickle Cell* / diagnosis
  • Anemia, Sickle Cell* / drug therapy
  • Anemia, Sickle Cell* / epidemiology
  • Anemia, Sickle Cell* / genetics
  • Anemia, Sickle Cell* / physiopathology
  • Anemia, Sickle Cell* / therapy
  • Antibiotic Prophylaxis
  • Antisickling Agents / administration & dosage
  • Antisickling Agents / therapeutic use
  • Blood Transfusion
  • Child
  • Child, Preschool
  • Diagnosis, Differential
  • Female
  • Genotype
  • Hematopoietic Stem Cell Transplantation
  • Hospitalization
  • Humans
  • Hydroxyurea / administration & dosage
  • Hydroxyurea / therapeutic use
  • Ibuprofen / administration & dosage
  • Ibuprofen / therapeutic use
  • Immunization
  • Infant
  • Infant, Newborn
  • Male
  • Morphine / administration & dosage
  • Morphine / therapeutic use
  • Pain / diagnosis
  • Pain / drug therapy
  • Pain / etiology
  • Pain Measurement
  • Penicillins / administration & dosage
  • Penicillins / therapeutic use
  • Risk Factors
  • Stroke / epidemiology
  • Stroke / prevention & control
  • Time Factors
  • Treatment Outcome

Substances

  • Analgesics, Non-Narcotic
  • Analgesics, Opioid
  • Antisickling Agents
  • Penicillins
  • Morphine
  • Ibuprofen
  • Hydroxyurea